Semaglutide, an injectable drug approved by the FDA as a treatment for Type 2 diabetes, has shown promising results in reducing symptoms and improving quality of life in people with obesity and the most common form of heart failure in a clinical trial.0 High-dose semaglutide (2.4 mg/weekly) could prevent and treat diabetes, cardiovascular disease, and related complications, including osteoarthritis and sleep apnea.1 Patients receiving semaglutide "are not just losing X number of pounds, but really improving their health."